chr10-86706708-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_007078.3(LDB3):​c.1074C>T​(p.Ala358Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0377 in 1,611,890 control chromosomes in the GnomAD database, including 1,352 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A358A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.027 ( 88 hom., cov: 33)
Exomes 𝑓: 0.039 ( 1264 hom. )

Consequence

LDB3
NM_007078.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:14

Conservation

PhyloP100: 0.0710

Publications

5 publications found
Variant links:
Genes affected
LDB3 (HGNC:15710): (LIM domain binding 3) This gene encodes a PDZ domain-containing protein. PDZ motifs are modular protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins interact with each other in cytoskeletal assembly or with other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM domains. The LIM domain is a cysteine-rich motif defined by 50-60 amino acids containing two zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this gene have been associated with myofibrillar myopathy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been identified; all isoforms have N-terminal PDZ domains while only longer isoforms (1, 2 and 5) have C-terminal LIM domains. [provided by RefSeq, Jan 2010]
LDB3 Gene-Disease associations (from GenCC):
  • myofibrillar myopathy 4
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial dilated cardiomyopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-86706708-C-T is Benign according to our data. Variant chr10-86706708-C-T is described in ClinVar as Benign. ClinVar VariationId is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.071 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0569 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDB3NM_007078.3 linkc.1074C>T p.Ala358Ala synonymous_variant Exon 8 of 14 ENST00000361373.9 NP_009009.1 O75112-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDB3ENST00000361373.9 linkc.1074C>T p.Ala358Ala synonymous_variant Exon 8 of 14 1 NM_007078.3 ENSP00000355296.3 O75112-1

Frequencies

GnomAD3 genomes
AF:
0.0274
AC:
4167
AN:
152166
Hom.:
88
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00654
Gnomad AMI
AF:
0.0658
Gnomad AMR
AF:
0.0202
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0510
Gnomad FIN
AF:
0.0274
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0427
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.0327
AC:
7970
AN:
244014
AF XY:
0.0355
show subpopulations
Gnomad AFR exome
AF:
0.00481
Gnomad AMR exome
AF:
0.0136
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.000439
Gnomad FIN exome
AF:
0.0278
Gnomad NFE exome
AF:
0.0443
Gnomad OTH exome
AF:
0.0359
GnomAD4 exome
AF:
0.0388
AC:
56602
AN:
1459606
Hom.:
1264
Cov.:
32
AF XY:
0.0397
AC XY:
28843
AN XY:
726062
show subpopulations
African (AFR)
AF:
0.00574
AC:
192
AN:
33442
American (AMR)
AF:
0.0129
AC:
577
AN:
44568
Ashkenazi Jewish (ASJ)
AF:
0.0109
AC:
284
AN:
26058
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39660
South Asian (SAS)
AF:
0.0582
AC:
5018
AN:
86148
European-Finnish (FIN)
AF:
0.0310
AC:
1632
AN:
52608
Middle Eastern (MID)
AF:
0.0323
AC:
178
AN:
5508
European-Non Finnish (NFE)
AF:
0.0420
AC:
46725
AN:
1111340
Other (OTH)
AF:
0.0330
AC:
1987
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3013
6027
9040
12054
15067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1674
3348
5022
6696
8370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
4162
AN:
152284
Hom.:
88
Cov.:
33
AF XY:
0.0274
AC XY:
2037
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00652
AC:
271
AN:
41554
American (AMR)
AF:
0.0201
AC:
308
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.0506
AC:
244
AN:
4818
European-Finnish (FIN)
AF:
0.0274
AC:
291
AN:
10622
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0427
AC:
2906
AN:
68012
Other (OTH)
AF:
0.0194
AC:
41
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
216
433
649
866
1082
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0313
Hom.:
79
Bravo
AF:
0.0235
Asia WGS
AF:
0.0180
AC:
64
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Jun 24, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 29, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1C Uncertain:1
Aug 21, 2014
Cytogenetics- Mohapatra Lab, Banaras Hindu University
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Cardiomyopathy Benign:1
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Myofibrillar myopathy 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jul 15, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.9
DANN
Benign
0.47
PhyloP100
0.071
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45459491; hg19: chr10-88466465; COSMIC: COSV53938805; API